Marpai Business Summary

Marpai, Inc. (MRAI) operates as a technology-driven healthcare payer company, primarily serving the self-insured employer market in the United States. The company generates revenue through a combination of administrative fees for Third-Party Administrator (TPA) services, Pharmacy Benefit Management (PBM) fees via its MarpaiRx subsidiary, and value-oriented health plan services. Its business model leverages a proprietary AI-powered platform to predict and prevent costly health events, thereby reducing medical claims for employers. Primary business segments include health plan administration, PBM services, and complementary care management solutions such as actuarial and bill review services. Marpai competes directly with healthcare technology and payer firms such as EUDA Health, P3 Health Partners, and GoHealth, positioning itself as a niche, AI-first alternative that optimizes cost-containment for lower-middle market employers. The leadership team is led by CEO and President Damien Lamendola, a healthcare entrepreneur who previously founded WellDyne and Continental Benefits and currently holds a significant equity stake through HillCour Investment Fund. The executive suite includes CFO Steve Johnson, a seasoned financial strategist and IPO investor, and Mimi Davis, who was appointed President of MarpaiRx in early 2026 to scale the company’s pharmacy operations. Marpai was co-founded by Chairman Yaron Eitan, a veteran venture capitalist. The company’s board and advisory team feature notable industry figures such as Winston Churchill and Mike Dendy, reflecting a deep pedigree in healthcare administration and cost-containment.